Novo Nordisk, which helped kickstart the GLP-1 craze by expanding a diabetes drug to obesity, is slimming down the prices of Ozempic and Wegovy. That won’t necessarily translate into steep revenue drops in 2026 though. Current projections still point to rising semaglutide sales next year, and a drop in price could lead to a boost…
Trump’s $150 Ozempic vow hits Novo, Lilly, even as Oz says ‘we have not negotiated those yet’
It took just one off-hand comment during a White House event about fertility treatments for President Trump to temporarily wipe tens of billions from the market cap of the world’s leading obesity drugmakers. Trump’s vow Thursday to bring Ozempic down to $150 per month, calling it “the fat-loss drug,” sent Novo Nordisk shares down 6.3%…
See how much Medicare plans to cut drug prices for Eliquis, Jardiance and more
Medicare is taking its scalpel to drug prices, excising billions in costs for popular medications like Eliquis and Jardiance. The Biden-Harris Administration announced significant agreements with drug makers that would cut list prices by up to 79% for the first 10 drugs selected under the new Medicare drug price negotiation program. CMS announced last year…